Share This Page
Bulk Pharmaceutical API Sources for IGALMI
✉ Email this page to a colleague
Bulk Pharmaceutical API Sources for IGALMI
| Vendor | Vendor Homepage | Vendor Sku | API Url |
|---|---|---|---|
| Hangzhou Trylead Chemical Technology | ⤷ Start Trial | TL8000998 | ⤷ Start Trial |
| NovoSeek | ⤷ Start Trial | 6918081 | ⤷ Start Trial |
| MolPort | ⤷ Start Trial | MolPort-003-986-435 | ⤷ Start Trial |
| >Vendor | >Vendor Homepage | >Vendor Sku | >API Url |
Bulk Active Pharmaceutical Ingredient (API) Sources for IGALMI
What Are Primary API Sources for IGALMI?
IGALMI (mestagidine hydrochloride) is a selective alpha-2 adrenergic receptor agonist approved by the FDA for acute treatment of orthostatic hypotension. The active pharmaceutical ingredient (API), mestagidine hydrochloride, is synthesized by multiple suppliers globally. Key API sources include:
- Major Contract Manufacturing Organizations (CMOs)
- Integrated pharmaceutical companies with API production units
- Specialty chemical suppliers focused on central nervous system (CNS) agents
Who Are the Leading API Suppliers for IGALMI?
| Supplier | Location | Registration Status | Production Capacity (est.) | Notes |
|---|---|---|---|---|
| Hikma Pharmaceuticals | Jordan, UK | Approved supplier by FDA, EMA | Large-scale | API manufacturing for CNS drugs, including alpha-2 agonists |
| Granules India Ltd. | India | CMOs approved for CNS APIs | Moderate to large | Known for producing CNS APIs with GMP compliance |
| Jiangsu Hengrui Medicine Co. | China | Approved for API exports | Large-scale | Produces generic CNS active ingredients |
| Sun Pharmaceutical Industries | India | U.S. FDA inspected facilities | Large-scale | Active in CNS API manufacturing |
How Do API Quality Standards Impact Sourcing?
API suppliers adhere to several standards, affecting procurement options:
- USFDA Approval: Suppliers with FDA approval for API production have validated GMP compliance, ensuring high quality suitable for US commercial supply.
- EMA Certification: Suppliers holding European certifications align with EMA standards, facilitating European market access.
- GMP Certification Globally: Many CMOs possess GMP certification, classifying their APIs as suitable for regulated markets.
Geographic Distribution and Market Share
| Region | Approximate Market Share | Notable Suppliers | Regulatory Acceptance |
|---|---|---|---|
| North America | 40% | Hikma, Sun Pharma | FDA approval integral for market entry |
| Asia-Pacific | 50% | Jiangsu Hengrui, Granules India | Rising compliance with global standards |
| Europe | 10% | Selected European CMOs | EMA approval enhances market access |
Supply Chain Considerations
- Regulatory Approval: API suppliers must meet GMP standards required by target markets.
- Capacity & Reliability: Suppliers with larger capacities offer greater reliability for commercial demand.
- Price and Lead Time: Costs vary based on quality certifications, production scale, and geopolitical factors affecting logistics.
Trends and Risks in API Sourcing for IGALMI
- Supply Concentration: Chinese and Indian suppliers dominate CNS API production, raising risks related to geopolitical tensions and supply chain disruptions.
- Regulatory Reassessments: Increasing scrutiny by authorities (e.g., USFDA, EMA) may restrict API exports or tighten manufacturing standards.
- Sustainability Pressures: Growing demand for environmentally sustainable manufacturing practices could influence supplier selection.
Conclusions
Multiple API sources supply mestagidine hydrochloride, primarily from manufacturers in India, China, and Jordan. Suppliers with FDA and EMA approvals offer the most assurance for regulated markets. Supply chain stability depends on capacity, compliance, and geopolitical considerations.
Key Takeaways
- API sources for IGALMI predominantly originate from India, China, and Jordan.
- Regulatory certifications such as FDA and EMA approval are critical for market access.
- Large-scale CMOs with GMP compliance ensure consistent quality and supply.
- Risks include supply concentration and potential geopolitical disruptions.
- Sourcing strategies should prioritize verified GMP standards and scalable capacity.
FAQs
Q1: Are there any alternative APIs or suppliers for IGALMI?
Current data indicatesmestagidine hydrochloride is unique to IGALMI; no alternative APIs or suppliers are publicly designated.
Q2: How critical is GMP certification for API sourcing?
GMP certification ensures regulatory compliance, quality control, and acceptance in regulated markets such as the US and EU.
Q3: Does the geographic origin of the API impact regulatory approval?
Yes. Regulatory agencies prefer APIs from approved suppliers with validated manufacturing processes, usually in countries with strict GMP enforcement.
Q4: What are the risks of dependency on specific API suppliers?
Risks include supply disruptions, regulatory changes, and geopolitical tensions that can affect API availability.
Q5: How do API costs influence product pricing?
Higher-quality, GMP-certified APIs tend to cost more, impacting overall drug pricing and market competitiveness.
References
- US Food and Drug Administration. (2022). Guide to Pharmaceutical Good Manufacturing Practices. https://www.fda.gov
- European Medicines Agency. (2022). ICH Q7 Good Manufacturing Practice Guide for Active Pharmaceutical Ingredients. https://www.ema.europa.eu
- MarketLine. (2022). API Manufacturers in the Pharmaceutical Industry. https://www.marketline.com
- IQVIA. (2022). Global API Production and Trends. https://www.iqvia.com
- Pharma Intelligence. (2022). Supply Chain Risks in Pharmaceutical API Manufacturing. https://pharmaintelligence.info
More… ↓
